Dia-PT R LIQ


  • Cat. No.: 84048; 84096
    Unit: 12x4ml; 12x8ml
    CE reg. no.: HU/CA01/17656/11

    Dia-PT R LIQ is a thromboplastin produced by recombinant genetic technology in Escherichia Coli, in dissolved ready to use form, without the necessity to reconstitute it.

    Intended Use

    (For In Vitro Diagnostic Use Only)

    Dia-PT R LIQ is a thromboplastin produced by recombinant genetic technology in Escherichia Coli, in dissolved ready to use form, without the necessity to reconstitute it.

     

    Summary and Background

    Dia-PT R LIQ thromboplastin is a recombinant human tissue factor with artificial lipids and calcium ions. This reagent is used for determination of Prothrombin Time (PT). The PT according to Quick is a sensitive screening test for the extrinsic coagulation pathway. Dia-PT R LIQ as a reagent for PT is highly sensitive to vitamin K antagonists, decreased level of factors in extrinsic pathway (factor II, V, VII, and X), hereditary or acquired coagulation disorders and liver failure. Therefore, the PT with Dia-PT R LIQ is used for presurgical screening and monitoring for oral anticoagulant therapy (OAT).

     

    Principle

    Dia-PT R LIQ when added to patient’s plasma induces the formation of fibrin clot, which is measurable with optical or mechanical coagulation analysers.